Skip to main content

A Transcriptional Switch Between KLF Activators and Repressors in Maturing Neocortex

NINDS - National Institute of Neurological Disorders and Stroke

open
OpenLast verified: 2026-06-20

About This Grant

Project Summary / Abstract The mammalian brain is not fully developed at birth. In humans, mice and other mammals, neocortical neurons largely complete neurogenesis, migration and the initial stages of axonal outgrowth in the embryo, but most refinement and myelination of axonal connections occurs after birth, and is profoundly influenced by neuronal activity and the hormonal milieu. These and other changes in the cellular and synaptic physiology of cortical neurons are achieved in part through massive changes in gene expression involving both upregulation of genes important for mature circuit function, and downregulation of transcriptional programs needed for proliferation, migration and axon outgrowth. Mechanisms controlling this transition are not well understood. Recent CRISPRi loss of function experiments identified a developmental switch between activators and repressors in the Kruppel-like (KLF) family of transcription factors that contribute to this transition. KLF activators are turned on before birth and activate a coordinated program of genes known to be necessary for axonal outgrowth. But unlike many genes with roles in early development, these genes are then turned off by a fall in KLF activators and a rise in redundant KLF repressors, a conserved event that occurs around the time of eye opening in rodents and around birth in humans. Here we address two important questions about this switch: 1) how is it initiated? And, 2) what developmental benefit might accrue from turning off a transcriptional program for axon outgrowth? We hypothesize that the benefit lies in permitting a period of extensive axonal refinement and pruning to proceed unopposed. We hypothesis that this transition is driven by a burst in thyroid hormone (TH) occurring at the same time. The more important repressor, Klf9 is known to be a TH target in multiple systems, and developmental loss of TH is known to impair pruning of cortical axons and if not treated, to produce profound and lasting Intellectual Disability. We will test these hypotheses by determining whether Klf9 expression depends on TH in cortical neurons and whether this is cell autonomous and reversible. We will also test whether repressors Klf9 and Klf13 are required for normal pruning of corticospinal and callosal axons, and whether increasing their expression is sufficient to rescue pruning after loss of TH. These experiments will empower a broader research program into mechanisms by which axonal refinement is coordinated with other features of circuit maturation under the control of neuronal activity and hormonal signaling.

Grant Summary

A Transcriptional Switch Between KLF Activators and Repressors in Maturing Neocortex is a NINDS - National Institute of Neurological Disorders and Stroke grant providing up to $221K for university, nonprofit, healthcare org. Applications are due 2027-12-31 (open). Check eligibility and apply with FindGrants.

Not quite the right fit?

Search 9,000+ open grants, or get matches ranked for your organization — free.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $221K

Deadline

2027-12-31

Complexity
Medium
  1. 1Confirm your organization is eligible for A Transcriptional Switch Between KLF Activators and Repressors in Maturing Neocortex from NINDS - National Institute of Neurological Disorders and Stroke, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NINDS - National Institute of Neurological Disorders and Stroke before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NINDS - National Institute of Neurological Disorders and Stroke's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

A Transcriptional Switch Between KLF Activators and Repressors in Maturing Neocortex: Frequently Asked Questions

Who is eligible for the A Transcriptional Switch Between KLF Activators and Repressors in Maturing Neocortex?

A Transcriptional Switch Between KLF Activators and Repressors in Maturing Neocortex is offered by NINDS - National Institute of Neurological Disorders and Stroke and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the A Transcriptional Switch Between KLF Activators and Repressors in Maturing Neocortex provide?

A Transcriptional Switch Between KLF Activators and Repressors in Maturing Neocortex provides up to $221K per award from NINDS - National Institute of Neurological Disorders and Stroke. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the A Transcriptional Switch Between KLF Activators and Repressors in Maturing Neocortex deadline?

Applications for A Transcriptional Switch Between KLF Activators and Repressors in Maturing Neocortex are due 2027-12-31 (open). Because deadlines can change, verify the date with the funder, NINDS - National Institute of Neurological Disorders and Stroke, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the A Transcriptional Switch Between KLF Activators and Repressors in Maturing Neocortex?

To apply for A Transcriptional Switch Between KLF Activators and Repressors in Maturing Neocortex, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NINDS - National Institute of Neurological Disorders and Stroke.